Solomon Luo

Title: Solomon Luo: Innovator in Binding Proteins and Chimeric Antigen Receptor T Cells

Introduction

Solomon Luo is a notable inventor based in Orwigsburg, Pennsylvania. He has made significant contributions to the field of biotechnology, particularly in the development of methods for detecting cells with specific granules. His innovative work has the potential to impact various medical applications.

Latest Patents

Luo holds a patent for "Binding proteins and chimeric antigen receptor T cells targeting GASP-1 granules and uses thereof." This patent describes a method for detecting cells that express G protein coupled receptor-associated sorting protein 1 (GASP-1). The detection method involves contacting the cells with a binding protein that specifically binds to GASP-1 and identifying the cells that have granules bound to this protein. The granules may be located in the cytosol or on the cell surface. Additionally, the patent outlines methods for producing T-cells that incorporate a chimeric antigen receptor, as well as methods for treating diseases associated with GASP-1.

Career Highlights

Luo is currently associated with Proplex Technologies, LLC, where he continues to advance his research and development efforts. His work is characterized by a strong focus on innovative solutions in the field of cellular biology and therapeutic applications.

Collaborations

Some of his notable coworkers include Frank N. Chang and George P. Tuszynski. Their collaborative efforts contribute to the ongoing research and development initiatives at Proplex Technologies.

Conclusion

Solomon Luo's contributions to the field of biotechnology, particularly through his patent on binding proteins and chimeric antigen receptor T cells, highlight his innovative spirit and dedication to advancing medical science. His work has the potential to lead to significant advancements in the detection and treatment of diseases.